Alfa Chemistry has made a remarkable stride in the field of synthetic biology with the recent renewal of its oligonucleotide series products. This updated lineup includes a range of advanced ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Humacyte has priced the product at $29,500 per unit. This is more expensive than the synthetic vessels already on the market.

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, d riven by rising adoption of biologics in disease management, ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 82 tables and 75 figures, this 197-page report ?North America Active Pharmaceutical Ingredients (API) Market 2022-2032 by ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

The 3D cell culture industry is poised for substantial growth from 2025 to 2035, driven by advancements in biotechnology and ...

DetraPel, Inc., a clean-tech advanced materials company, will relocate its headquarters and advanced manufacturing operations ...

Request Sample of the Report on Global Cell Culture Hydrogel Market 2035 - The growth of the cell culture hydrogel market is driven by surge in prevalence of chronic diseases and aging population, ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.